Failure of dietary α-difluoromethylornithine to inhibit gastric carcinogenesis in rats after 8 weeks of treatment with N-methyl-N'-nitro-N-nitrosoguanidine and sodium chloride

Cancer Letters

Volumn 120, Issue 1, 1997, Pages 95-100

  Tanakamaru, Zen Yo ^a,b   Nishikawa, Akiyoshi ^a   Furukawa, Fumio ^a   Imazawa, Takayoshi ^a   Lee, In Seon ^a,c   Kasahara, Ken Ichiro ^a   Tanaka, Takuji ^b   Takahashi, Michihito ^a  

^a NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

^b GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Keimyung University   (South Korea)

Author keywords

DFMO; MNNG; Rat; Stomach carcinogenesis

Indexed keywords

EFLORNITHINE; METHYLNITRONITROSOGUANIDINE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; HYPERPLASIA; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; STOMACH CARCINOGENESIS;

ADENOCARCINOMA; ANIMALS; CELL DIVISION; CHEMOPREVENTION; EFLORNITHINE; MALE; METHYLNITRONITROSOGUANIDINE; RATS; RATS, WISTAR; SODIUM CHLORIDE; STOMACH NEOPLASMS;

ANIMALIA; RATTUS NORVEGICUS;

EID: 0030731438     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(97)00291-7     Document Type: Article

References (27)

1. B.E. Butterworth, J.A. Popp, R.B. Conolly, T.L. Goldsworthy, Chemically induced cell proliferation in carcinogenesis, in: H. Vainio, P. Magee, D. McGregor, A.J. McMichael (Eds.), Mechanisms of Carcinogenesis in Risk Identification, IARC Scientific Publication No. 116, IARC, Lyon, 1992, pp. 279-305.
2. 3-treated animals. Cancer Res. 47:1987;5031-5035.
3. Homma Y., Kakizoe T., Samma S., Oyasu R. Inhibition of N-butyl-N-(4-hydroxybutyl)nitrosamine-induced rat urinary bladder carcinogenesis by α-difluoromethylornithine. Cancer Res. 47:1987;6176-6179.
4. 3 derivative, on glandular stomach carcinogenesis induced in rats by N-methyl-N′-nitro-N-nitrosoguanidine and sodium chloride. Cancer Res. 56:1996;2767-2770.
5. Katz A., Kahana C. Transcriptional activation of mammalian ornithine decarboxylase during stimulated growth. Mol. Cell Biol. 7:1987;2641-2643.
6. Kingsnorth A.N., King W.W.K., Diekema K.A., McCann P.P., Ross J.S., Malt R.A. Inhibition of ornithine decarboxylase with 2-difluoromethylornithine: reduced incidence of dimethylhydrazine-induced colon tumors in mice. Cancer Res. 43:1983;2545-2549.
7. Kojima T., Tanaka T., Kawamori T., Hara A., Mori H. Chemopreventive effects of dietary DL-α-difluoromethylornithine, an ornithine decarboxylase inhibitor, on initiation and postinitiation stages of diethylnitrosamine-induced rat hepatocarcinogenesis. Cancer Res. 53:1993;3903-3907.
8. Lehnert T., Buhl K., Ivankovic S. Inhibition of gastric tumorigenesis by α-difluoromethylornithine in rats treated with N-methyl-N′-nitro-N-nitrosoguanidine. J. Cancer Res. Clin. Oncol. 119:1993;594-598.
9. Luk G.D., Zhang S.-Z., Hamilton S.R. Effects of timing of administration and dose of difluoromethylornithine on rat colonic carcinogenesis. J. Natl. Cancer Inst. 81:1989;421-427.
10. Nigro N.D., Bull A.W., Boyd M.E. Inhibition of intestinal carcinogenesis in rats: effect of difluoromethylornithine with piroxican or fish oil. J. Natl. Cancer Inst. 77:1986;1309-1313.
11. Nigro N.D., Bull A.W., Boyd M.E. Importance of the duration of inhibition on intestinal carcinogenesis by difluoromethylornithine in rats. Cancer Lett. 35:1987;153-158.
12. Nishikawa A., Furukawa F., Mitsui M., Enami T., Kawanishi T., Hasegawa T., Takahashi M. Inhibitory effect of calcium chloride on gastric carcinogenesis in rats after treatment with N-methyl-N′-nitro-N-nitrosoguanidine and sodium chloride. Carcinogenesis. 13:1992;1155-1158.
13. Nishikawa A., Furukawa F., Imazawa T., Toyoda K., Mitsui M., Hasegawa T., Takahashi M. Effects of hickory smoke condensate on gastric carcinogenesis in Wistar rats after treatment with N-methyl-N′-nitro-N-nitrosoguanidine and sodium chloride. Food Chem. Toxicol. 31:1993;25-30.
14. Nishikawa A., Furukawa F., Imazawa T., Ikezaki S., Hasegawa T., Takahashi M. Effects of caffeine on glandular stomach carcinogenesis induced in rats by N-methyl-N′-nitro-N-nitrosoguanidine and sodium chloride. Food Chem. Toxicol. 33:1995;21-26.
15. Nishikawa A., Furukawa F., Mitsui M., Enami T., Imazawa T., Ikezaki S., Takahashi M. Dose-dependent promotion effects of potassium chloride on glandular stomach carcinogenesis in rats after initiation with N-methyl-N′-nitro-N-nitrosoguanidine and the synergistic influence with sodium chloride. Cancer Res. 55:1995;5238-5241.
16. Pegg A.E., McCann P.P. Polyamine metabolism and function. Am. J. Physiol. 243:1982;C212-C221.
17. Rao C.V., Tokumo K., Rigotty J., Zang E., Kelloff G., Reddy B.S. Chemoprevention of colon carcinogenesis by dietary administration of piroxicam, α-difluoromethylornithine, 16α-fluoro-5-androsten-17-one, and ellagic acid individually and in combination. Cancer Res. 51:1991;4528-4534.
18. Reddy B.S., Nayini J., Tokumo K., Rigotty J., Zang E., Kelloff G. Chemoprevention of colon carcinogenesis by concurrent administration of piroxicam, a nonsteroidal antiinflammatory drug with DL-α-difluoromethylornithine, an ornithine decarboxylase inhibitor, in diet. Cancer Res. 50:1990;2562-2568.
19. Schedin P.J., Strange R., Singh M., Kaech M.R., Fontaine S.C., Thompson H.J. Treatment with chemopreventive agents, difluoromethylornithine and retinyl acetate, results in altered mammary extracellular matrix. Carcinogenesis. 16:1995;1787-1794.
20. Sugimura T., Fujimura S. Tumor production in glandular stomach of rats by N-methyl-N′-nitro-N-nitrosoguanidine. Nature. 216:1967;943-944.
21. Takahashi M., Kokubo T., Furukawa F., Kurokawa Y., Hayashi Y. Effects of sodium chloride, saccharin, phenobarbital and aspirin on gastric carcinogenesis in rats after initiation with N-methyl-N′-nitro-N-nitrosoguanidine. Gann. 75:1984;494-501.
22. Takahashi M., Nishikawa A., Furukawa F., Enami T., Hasegawa T., Hayashi Y. Dose-dependent promoting effects of sodium chloride (NaCl) on rat glandular stomach carcinogenesis initiated with N-methyl-N′-nitro-N-nitrosoguanidine. Carcinogenesis. 15:1994;1429-1432.
23. Takigawa M., Verma A.K., Simsiman R.C., Boutwell R.K. Inhibition of mouse skin tumor promotion and of promoter-stimulated epidermal polyamine biosynthesis by α-difluoromethylornithine. Cancer Res. 43:1983;3732-3738.
24. Tanaka T., Kojima T., Hara A., Sawada H., Mori H. Chemoprevention of oral carcinogenesis by DL-α-difluoromethylornithine, an ornithine decarboxylase inhibitor: dose-dependent reduction in 4-nitroquinoline 1-oxide-induced tongue neoplasms in rats. Cancer Res. 53:1993;772-776.
25. Tempero M.A., Nishioka K., Knott K., Zetterman R.K. Chemoprevention of mouse colon tumors with difluoromethylornithine during and after carcinogen treatment. Cancer Res. 49:1989;5793-5797.
26. Tsukahara T., Tamura M., Yamazaki H., Kurihara H., Matsuzaki S. The additive effect of α-difluoromethylornithine (DFMO) and radiation therapy on a rat glioma model. J. Cancer Res. Clin. Oncol. 118:1992;171-175.
27. Weeks C.E., Herrmann A.L., Nelson F.R., Slaga T.J. Difluoromethylornithine, an irreversible inhibitor of ornithine decarboxylase, inhibits tumor promoter-induced polyamine accumulation and carcinogenesis in the mouse skin. Proc. Natl. Acad. Sci. USA. 79:1982;6028-6032.